SII

Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…

Currently, the Serum Institute of India is the only domestic player that was able to launch its homegrown HPV vaccine, 'Cervavac',…

Speaking during the World Economic Forum (WEF) Annual Meeting 2023, Poonawalla said he is optimistic about the cooperation

The National Technical Advisery Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter

The DCGI's approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control…

Since the launch of the anti-COVID vaccination drive, SII has so far provided 170 crore doses of Covishield to the government

The vaccine will be administered to those aged 18 years and above, and those who have been administered two doses of Covishield or…

The bivalent vaccine is designed to target both major strains of ebola virus

The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility

The Serum Institute of India (SII) will start supplying the HPV vaccine to the Indian government in early 2023